Treatment of aspiration pneumonitis requiring intubation and mechanical ventilation

On 10/07/2007, a new orphan medicinal product was registered into the community register of orphan medicinal products under the EU orphan designation number 457. The active ingredient is Lusupultide for treatment of aspiration pneumonitis requiring intubation and mechanical ventilation.